Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor. [electronic resource]
- EMBO molecular medicine 02 2020
- e9910 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1757-4684
10.15252/emmm.201809910 doi
Androgens--therapeutic use Animals Cachexia--drug therapy Drug Resistance, Neoplasm Female Histone Deacetylase Inhibitors--therapeutic use Male Mice Mice, Inbred C57BL Neoplasms